|
|
Probability
that PHT Is Effective: Page 2
Evidence
Over the years frustration
has caused me to write a few stories about evidence. Put together they
are pertinent.
The Placebo
When one is trying
to determine if a medicine is effective, the use of a placebo is sensible.
If a doctor gives a patient a medication with the expectation of helping
a patient, the patient may pick up on that expectation and rationalize
that it’s going to help him. Psychologically this might actually help
for a while. If a medication is useful, comparing it to a placebo will
demonstrate that it was not expectation that made the patient feel better,
but the medication itself. A placebo is not needed with a drug that is
effective in a clearcut fashion. But initially that might not be known,
so starting with a placebo makes sense.
The Negative Placebo
Suppose a patient
has a disorder and the doctor gives him a drug with the hope it will help
him. Suppose the patient rationalizes that it’s going to help and gets
a psychological lift, which wears off after a while. Then the doctor prescribes
a second drug to the patient. This time the patient is less optimistic,
but a little bit of wishful thinking may be left. This drug doesn’t work
and the doctor gives a third one. This time the patient’s wish-thinking
device is depleted and he’s not expecting any results. You could say he’s
placebo-proof. Let’s say that drug doesn’t work either, and a fourth drug
is given. By now, there’s a negative expectation by the patient. He expects
the drug not to work because, if the first three didn’t, why should the
fourth? There are thousands of studies on PHT in which a variety of drugs
had been tried. These are well-controlled studies—the drugs that had been
used had the effect of a placebo/ In many, they might have been better
than placebo studies—there might have been a negative placebo effect.
Substantial Evidence
In the Federal Food,
Drug and Cosmetic Act the FDA is required to have “substantial evidence
of effectiveness.” The word substantial, in this context, cannot mean
quantity. A study of 10,000 cases could be inconclusive. The evidence
from a few cases can be “substantial.” Let’s take one example of how the
evidence from just eight cases could be substantial.
For the purpose of
this example, we eliminate the possibility of collusion or hoax. Suppose
there is a government station in North Carolina that is set up to receive
reports of UFOs. On average they receive one call a day. Suppose that
one night, between 3:00 and 3:10, eight calls come into this station all
reporting similar observations, to wit, that a huge ball of fire was seen
slowly floating a few hundred yards overhead, and that suddenly at tremendous
speed it went upward, and disappeared from sight. Remembering our premise
that collusion is eliminated, what are the probabilities that this really
happened?
Since one call a day,
at random times, is the average, the first call at 3:00 AM means no more
than any other call received by the station. The second call could have
been a coincidence. However, because it was within a ten-minute span of
the first, this coincidence would occur, on average, once in 144 days
(there are 144 ten-minute spans in twenty-four hours). The third call
would be one heck of a coincidence, one hundred forty-four times one hundred
forty-fourths of a chance. By the eighth call, the odds that there had
been an unusual occurrence around 3 AM would be:
1/144 x 1/144 x 1/144
x 1/144 x 1/144 x 1/144 x 1/144, or 1,283,918,464,548,864–to–1.
This is “substantial
evidence.”
Now, in the UFO example,
we took a premise that we couldn’t take in real life, that collusion or
hoax were impossible. The fact is that collusion would seem far more likely
than anything else, and the investigators of this matter would spend a
lot of time proving or disproving this.
We now come to the
real life proposition, the evidence that PHT is a widely versatile medicine.
Here the probability of collusion is ruled out by applying common sense
to the facts.
Let’s look at the
facts before we apply the common sense. Physicians in at least thirty-eight
countries have reported PHT to be useful for more than seventy symptoms
and disorders, in over 400 medical journals, written in seventeen different
languages. This information started appearing in the literature in 1938
and has increased steadily to this date. It’s obvious that the reporting
physicians did not know of the work of more than a few of their colleagues.
Common sense rules out collusion. Thus, the probability that PHT is a
widely versatile drug is of the same order of magnitude as in the UFO
example.
The Rules of Evidence
The Rules of Evidence
have something in common with the Law of Gravity. Neither can be amended
by Congress nor by any branch of Government. The Rules of Evidence are
simple. They are the application of common sense to probability.
Let us apply the Rules
to the question of whether or not phenytoin is useful for thought, mood
and behavior disorders. The material on which this exercise is based is
found in the Thought, Mood and Behavior section of The
Broad Range of Clinical Use of Phenytoin.
There are many kinds
of evidence: Studies with placebo. Studies in which a drug is effective
after other drugs have failed. Trials in which a drug is found effective—is
withdrawn and symptoms return, reinstituted and symptoms disappear. Clinical
studies in which improvements are confirmed by laboratory means. All of
these methods have been used in establishing PHT’s effectiveness.
Before arriving at
a probability figure for thought, mood and behavior disorders, we will
define them, for these purposes, to be problems of excessive anger and
related symptoms such as impatience, irritability, impulsivity, hostility
and violence; excessive fear and related symptoms such as worry, anxiety,
apprehension, depression; also uncontrolled thinking, occupied by negative
thoughts and interfering with concentration.
(In four papers PHT
was not found “significantly” effective (not necessarily ineffective).
For these purposes we allowed the four papers to eliminate ten positive
papers that we have assessed the chance of being correct of one in two.)
To arrive at an overall probability figure of PHT’s usefulness for thought,
mood and behavior, we assess individual probability figures to each of
the studies. This is done by estimate, but since most of the authors assess
the chance of their own work being correct in excess of 19-to-1 or 99-to-1,
the following estimates are conservative:
Probability
that PHT is effective
|
| |
1
in 2 |
| For
each of the first seven reports, |
1
in 2 |
| controlled
by phenobarbital |
1
in 2 |
| and/or
bromides, we assess |
1
in 2 |
| the
probability of being correct of |
1
in 2 |
| 1
chance in 2. |
1
in 2 |
| |
1 in 2
|
|
Lindsley
and Henry, the first paper in
non-epileptics,
in problem children
|
1
in 2 |
| Brown
and Solomon, in delinquent boys |
1
in 2 |
|
Silverman,
in a jail study, 64 prisoners, double-blind crossover, placebo—also
other drugs
|
5
in 6 |
| Bodkin,
observations of 102 nervous patients |
3
in 4 |
| Goodwin,
20 patients out of 20 nervous patients |
2
in 3 |
|
Walker and
Kirkpatrick, 10 behavioral problem children out of 10, all improved
|
2
in 3 |
|
Zimmerman,
200 children with severe behavior disorders, 70 percent of cases
improved
|
3
in 4 |
|
Chao, Sexton
and Davis, 296 children, response rapid, often striking
|
4
in 5 |
| Jonas,
in his book, Ictal and Subictal Neurosis 162 patients—over
12 years |
3
in 4 |
| Lynk
and Amidon, 125 delinquents |
3
in 4 |
| Dreyfus,
80 patients |
1
in 2 |
| Rossi,
behavioral problem children |
1
in 2 |
| Turner,
46 of 56 adult neurotic patients |
2
in 3 |
| Tec,
15 years’ experience |
2
in 3 |
|
Boelhouwer,
et al., 78 patients, double-blind crossover and placebo
|
4
in 5 |
| Baldwin,
109 children with behavior problems |
3
in 4 |
|
Stephens
and Shaffer, double-blind, 30 adult outpatients
|
4
in 5 |
|
Goldberg
and Kurland, double-blind, 47 retardates, ages 9 to 14
|
3
in 4 |
| Daniel,
aged patients |
1
in 2 |
| Bozza,
21 slightly brain damaged retarded children |
1
in 2 |
| Alvarez,
in a book covering 25 years’ experience |
5
in 6 |
|
Stephens
and Shaffer, second double-blind with 10 patients
|
3
in 4 |
|
Maletsky,
episodic dyscontrol, 22 adults—other drugs had failed.
|
3
in 4 |
|
Maletsky
and Klotter, episodic dyscontrol, 24 adults, double-blind with
placebo
|
4
in 5 |
| Solomon
and Kleeman, 2 cases episodic dyscontrol |
1
in 2 |
|
Bach-Y-Rita,
et al., 130 adults with assaultive and destructive behavior
|
3
in 4 |
|
Kalinowsky
and Putnam, 60 psychotic patients, improvement in over half
|
1
in 2 |
|
Freyhan,
40 psychiatric patients, behaviorial problems
|
2
in 3 |
|
Kubanek and
Rowell, double-blind, 73 psychotic patients unresponsive to
other drugs.
|
4
in 5 |
| Haward,
double-blind, 20 psychotic patients |
3
in 4 |
| Haward,
three double-blind studies: |
3
in 4 |
|
concentration—last
study, 59 pilots
|
3
in 4 |
|
Smith and
Lowrey, 20 adult volunteers, double-blind—cognitive function
|
3
in 4 |
|
Smith and
Lowrey, 10 aged adults, double-blind crossover—cognitive function
|
2
in 3 |
|
Stambaugh,
hypoglycemia, unresponsive to dietary management—including 6 hour
glucose test
|
3
in 4 |
|
Wermuth,
et al., double-blind crossover, 19 “binge eaters”
|
2
in 3 |
| |
|
Based on the foregoing,
the chance that PHT is useful for Thought, Mood and Behavior disorders
is:
8,453,784,125,030,400,000-to-1.
PHT’s parameters of
safety have been established over a fifty-six–year period, by millions
of people taking it daily, for long periods of time. It has properties,
which, viewed together, set it apart from other drugs. It acts promptly,
calms without sedation, energizes without artificial stimulation, and
has beneficial side effects. PHT is not habit-forming.
Conclusion—Having
PHT listed in the Physicians’ Desk Reference (PDR) only as an anticonvulsant
is a grave injustice to the American public.
The Tuna Fish Story
Once upon a time some
people were shipwrecked on a desert island. Their only food was tiny fish
they caught daily. To get the most from the fish they constructed a machine
that ground them up, including the heads and tails. A year went by and
all the food the people ate went through the machine. Five years went
by, ten years, and still their food went through the machine.
One day a man caught
a tuna. “Now we will all have plenty to eat,” he said. “Put it through
the machine,” the people told him. “It’s too big,” he said, “it won’t
fit.” “Then we can’t eat it,” they said. The phenytoin story is too big.
It won’t fit in the FDA machine.
Next
Section: Observations on PHT
Advisory
|